Virdental - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 493,218 | 430,878 | 469,381 | 540,872 | 672,614 | 872,739 | 800,468 | 1,002,511 |
| Profit before tax | - | - | - | - | - | - | 46,261 | 54,705 |
| Net profit | 11,194 | 3,899 | 28,559 | 27,242 | 29,158 | 43,019 | 39,219 | 45,378 |
| Equity | 65,047 | 58,947 | 87,506 | 99,747 | 113,068 | 136,088 | 145,306 | 163,684 |
| Liabilities | 26,179 | 61,055 | 9,988 | 10,392 | 24,718 | 20,418 | 6,454 | 14,658 |
| Non-current assets | 26,382 | 20,295 | 14,207 | 32,857 | 26,700 | 20,542 | 53,288 | 0 |
| Current assets | 64,844 | 99,707 | 82,691 | 76,680 | 110,553 | 135,453 | 95,952 | 176,732 |
| Total assets | 91,226 | 120,002 | 96,898 | 109,537 | 137,253 | 155,995 | 149,240 | 176,732 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 47,620 | 69,270 | 23,421 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -7.1% | -12.6% | +8.9% | +15.2% | +24.4% | +29.8% | -8.3% | +25.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 12.3% | 3.2% | 29.5% | 24.9% | 21.2% | 27.6% | 26.3% | 25.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 17.2% | 6.6% | 32.6% | 27.3% | 25.8% | 31.6% | 27.0% | 27.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 2.3% | 0.9% | 6.1% | 5.0% | 4.3% | 4.9% | 4.9% | 4.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | 5.8% | 5.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.4 | 1.0 | 0.1 | 0.1 | 0.2 | 0.2 | 0.0 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 131,525 | 143,626 | 187,752 | 270,436 | 336,307 | 436,370 | 400,234 | 501,256 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Virdental - Social security debts
The company had no debts to Sodra
Virdental - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Virdental, UAB (code 301817588) is a Private Limited Liability Company operating in the wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, the company generated revenue of €1.00M and net profit of €45.4K, with a profit margin of 4.5%. Revenue increased by 25.2% year on year, and by 14.9% over two years, showing a recovery after the 2024 decline. Revenue was €872.7K in 2023, fell to €800.5K in 2024, and then rose above the 2023 level in 2025. Net profit followed a similar pattern, moving from €43.0K in 2023 to €39.2K in 2024 and €45.4K in 2025. The balance sheet remained solid, with total assets of €176.7K, equity of €163.7K and liabilities of €14.7K in 2025. The equity ratio was 92.6% and debt-to-equity 0.09, indicating very limited leverage. Asset turnover stood at 5.67x, while ROE was 27.7% and ROA 25.7%. Revenue per employee reached €501.3K and profit per employee €22.7K, pointing to strong productivity.